Search research articles
Contact Us
Filters
Showing results (111-120 of 202) with videos related to
Page
of 21
Sort By:
Lancet (London, England)
|
January 16, 1988
Biogenic amine adducts, monoamine oxidase inhibitors, and smoking
A A Boulton, P H Yu, K F Tipton
Journal of Medicinal Chemistry
|
October 2, 1992
Aliphatic propargylamines: potent, selective, irreversible monoamine oxidase B inhibitors
P H Yu, B A Davis, A A Boulton
Neuropathology and Applied Neurobiology
|
November 1, 2007
The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease
Z J Jiang, J S Richardson, P H Yu
BMJ (Clinical Research Ed.)
|
March 16, 1996
Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Selegeline may be toxic in presence of increased dopamine concentrations
P H Yu, C T Lai, A A Boulton
Applied Biochemistry and Biotechnology
|
June 13, 2000
Effects of trace levels of copper, chromium, and zinc ions on the performance of activated sludge
S N Sin, H Chua, W Lo, et al.
Applied Biochemistry and Biotechnology
|
June 13, 2000
Optimal production of polyhydroxyalkanoates in activated sludge biomass
C K Ma, H Chua, P H Yu, et al.
The Science of the Total Environment
|
March 22, 2001
The degradation of xenobiotic branched carboxylic acids in anaerobic sediment of the Pearl River in Southern China
H Chua, P H Yu, W Lo, et al.
Biochemical Pharmacology
|
November 15, 1981
Deuterium isotope effects on the enzymatic oxidative deamination of trace amines
P H Yu, S Barclay, B Davis, et al.
FEBS Letters
|
June 1, 1974
On the stoichiometry and reversibility of interaction between Neurospora protease I and its inhibitor
P H Yu, D Siepen, M R Kula, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1991
Studies on the properties of some peripheral MAO inhibitors
E Scarr, P H Yu, B A Davis, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 202) with videos related to
Sort By:
Page
of 21
Lancet (London, England)
|
January 16, 1988
Biogenic amine adducts, monoamine oxidase inhibitors, and smoking
A A Boulton, P H Yu, K F Tipton
Journal of Medicinal Chemistry
|
October 2, 1992
Aliphatic propargylamines: potent, selective, irreversible monoamine oxidase B inhibitors
P H Yu, B A Davis, A A Boulton
Neuropathology and Applied Neurobiology
|
November 1, 2007
The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease
Z J Jiang, J S Richardson, P H Yu
BMJ (Clinical Research Ed.)
|
March 16, 1996
Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Selegeline may be toxic in presence of increased dopamine concentrations
P H Yu, C T Lai, A A Boulton
Applied Biochemistry and Biotechnology
|
June 13, 2000
Effects of trace levels of copper, chromium, and zinc ions on the performance of activated sludge
S N Sin, H Chua, W Lo, et al.
Applied Biochemistry and Biotechnology
|
June 13, 2000
Optimal production of polyhydroxyalkanoates in activated sludge biomass
C K Ma, H Chua, P H Yu, et al.
The Science of the Total Environment
|
March 22, 2001
The degradation of xenobiotic branched carboxylic acids in anaerobic sediment of the Pearl River in Southern China
H Chua, P H Yu, W Lo, et al.
Biochemical Pharmacology
|
November 15, 1981
Deuterium isotope effects on the enzymatic oxidative deamination of trace amines
P H Yu, S Barclay, B Davis, et al.
FEBS Letters
|
June 1, 1974
On the stoichiometry and reversibility of interaction between Neurospora protease I and its inhibitor
P H Yu, D Siepen, M R Kula, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1991
Studies on the properties of some peripheral MAO inhibitors
E Scarr, P H Yu, B A Davis, et al.
Page
of 21